Centrient Pharmaceuticals is the leading manufacturer of beta-lactam antibiotics, and a provider of next generation statins and anti-fungals.  We produce and sell intermediates, active pharmaceutical ingredients and finished dosage forms.

 

Worldwide our employees work together to deliver cutting edge generics solutions that help to keep our customers ahead of the competition.

 

Headquartered in Rotterdam (Netherlands), we have manufacturing sites and sales offices in China, India, Egypt, the Netherlands, Spain, the USA and Mexico.

News

16 October 2019

Centrient Pharmaceuticals advocates for Collaboration on Antimicrobial Resistance at India-Netherlands Technology Summit in New Delhi

Read more

19, June 2019

Global  opportunity to tackle antibiotics production waste

Read more

1 May, 2019

Centrient Pharmaceuticals Initiates Patent Litigation in India Against Dalas Biotech Limited

Read more

25 February, 2019

Effective May 6th 2019, Ronald Merckx will be joining Centrient Pharmaceuticals as Chief Financial Officer and member of the Executive Committee and Management Board of Directors.

Read more

18 February, 2019

The Delhi High Court in India has issued an injunction, restraining Sinopharm Weiqida from exporting its “Amoxycillin Trihydrate” product to India, as it infringes the patent of Centrient Pharmaceuticals

Read more

PureActives

 

Copyright © 2018 Centrient Pharmaceuticals

Join the conversation

Follow us on Facebook Follow us on Twitter Follow us on LinkedIn
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.
Sustainable Antibiotics: our PureActives API are sustainable enzymatic antibiotics.